The immunological and pathological effects of STAT3 inhibition were further evaluated in a non-obese diabetic (NOD) mouse model.<h4>Results</h4>Single-cell transcriptomic analysis revealed enhanced IL-21/STAT3 signaling activity in CD4<sup>+</sup> T cell populations from children with T1D. This evidence concerns the gene CD4 and type 1 diabetes mellitus.